Trials / Conditions / Malignant Melanoma Stage III

Malignant Melanoma Stage III

9 registered clinical trials studyying Malignant Melanoma Stage III — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Mel NCT06794775	Hildur Helgadottir	Phase 3
Active Not Recruiting	Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma NCT04949113	The Netherlands Cancer Institute	Phase 3
Terminated	The IRMI-FMT Trial NCT04577729	Medical University of Graz	N/A
Completed	Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IF NCT04133948	The Netherlands Cancer Institute	Phase 1 / Phase 2
Completed	Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic NCT03493230	Centre Hospitalier Universitaire de Nice	N/A
Unknown	Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab NCT02977052	The Netherlands Cancer Institute	Phase 2
Completed	mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma NCT01676779	Universitair Ziekenhuis Brussel	Phase 2
Completed	Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Un NCT01302496	Bart Neyns	Phase 2
Completed	IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma NCT01189383	Baylor Research Institute	Phase 1 / Phase 2